BANGKOK, April 28 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab has launched its hugely popular weight-loss drug Wegovy in Thailand, an executive of the Danish drugmaker's local subsidiary ...

Thai healthcare solutions company Zuellig Pharma has announced that Mounjaro (tirzepatide), Eli Lilly’s (NYSE: LLY) ...

If you’re exploring diabetes or weight-loss medications, Ozempic and Wegovy have become two popular options of injectable treatments. Both medications support blood sugar control and weight loss ...

The companies will sell the drug at a reduced price of $499 a month. Consumers looking to start the popular weight loss drug Wegovy but lacking insurance coverage will soon have a new option.

Cost and supply chain issues might leave you looking into Wegovy alternatives. Saxenda, Zepbound, Xenical, and Qysmia are options to explore with your doctor. Share on Pinterest Getty Images/FG ...

Patients who took the frequently prescribed diabetes and weight-loss drugs Ozempic and Wegovy faced a greater risk of a stroke of the optic nerve, which can lead to blindness, according to a new ...

Then Bronder ran across some research about a weight loss drug called semaglutide (Wegovy). The drug mimics a naturally occurring hormone called GLP-1 that lessens cravings, increases satiation ...

Wegovy (semaglutide) is a brand-name subcutaneous injection (shot) prescribed for weight loss and to lower the risk of cardiovascular problems in some people. As with other drugs, Wegovy can cause ...

Wegovy is a brand-name subcutaneous injection prescribed for weight loss and reduction of cardiovascular risks. Its cost with and without insurance can depend on several factors, such as whether ...

BANGKOK (Reuters) -Novo Nordisk (NOVO-B.CO, NVO) has launched its hugely popular weight-loss drug Wegovy in Thailand, an executive of the Danish drugmaker's local subsidiary said on Monday, marking ...